Stay updated on Post Market Clinical Trial for Pamira ICD Lead Family

Sign up to get notified when there's something new on the Post Market Clinical Trial for Pamira ICD Lead Family page.
Latest website image capture
Clouds background image

Latest updates to the Post Market Clinical Trial for Pamira ICD Lead Family page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to the clinical safety and performance evaluation of the Pamira lead for post-market strategies in medical and healthcare publications.
    Difference
    0.2%
    Check dated 2024-06-06T14:38:20.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the inclusion and exclusion criteria for the study. This change provides more specific information about the health conditions and prior treatments required for participation.
    Difference
    15%
    Check dated 2024-05-22T21:15:45.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:52.000Z thumbnail image

Stay in the know with updates to Post Market Clinical Trial for Pamira ICD Lead Family

Enter your email address, and we'll notify you when there's something new on the Post Market Clinical Trial for Pamira ICD Lead Family page.